Please provide your email address to receive an email when new articles are posted on . Tempus announced the FDA has granted a breakthrough device designation to its ECG analysis platform for the ...

With this clearance, vMap’s clinical use now includes non-invasive localization of potential arrhythmia sources associated with atrial flutter mechanisms. This new capability broadens the range of ...

When your electrical system is working normally, the two upper chambers of the heart (atria) contract and pump blood into the two lower chambers (ventricles) in a well-coordinated way. This results in ...

Madrid, Spain – 29 August 2025: A mail-based atrial fibrillation (AF) screening programme with ECG-patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure in ...

Narrow QRS complexes occur regularly. This tracing suggests either atrial flutter or ventricular tachycardia. It is not atrial flutter, however. If it were, the QRS complexes occurring regularly would ...

Dr. Hugh Calkins answers the question: 'Atrial Fibrillation vs. Atrial Flutter?' — -- Question: My doctor told me I sometimes have atrial fibrillation and at other times have atrial flutter. What ...

Researchers in Canada and Germany conducted the SCREEN-AF trial, a multicenter, open-label, randomized clinical trial of noninvasive, home-based AF screening interventions in community-dwelling older ...

SAN DIEGO--(BUSINESS WIRE)--Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced it has received FDA 510(k) clearance for its next-generation vMap ® ...